CHU Limoges CHU Dupuytren ( Site 0608)

Limoges 87042

0 studies enrolling now · 1 studies all time

What they study most

Squamous Cell Carcinoma

Studies at this site

• Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629) — Completed